High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)-Reference-Cited by-同舟云学术

High-dose methotrexate-based immuno-chemotherapy for elderly primary CNS lymphoma patients (PRIMAIN study)

Published:2016-11-15 Issue:4 Volume:31 Page:846-852
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Fritsch K,Kasenda B,Schorb E,Hau P,Bloehdorn J,Möhle R,Löw S,Binder M,Atta J,Keller U,Wolf H-H,Krause S W,Heß G,Naumann R,Sasse S,Hirt C,Lamprecht M,Martens U,Morgner A,Panse J,Frickhofen N,Röth A,Hader C,Deckert M,Fricker H,Ihorst G,Finke J,Illerhaus G

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu2016334.pdf

Reference22 articles.

1. Panageas KS, Elkin EB, DeAngelis LM, Ben-Porat L, Abrey LE . Trends in survival from primary central nervous system lymphoma, 1975–1999: a population-based analysis. Cancer 2005; 104: 2466–2472.

2. Ferreri AJM, Reni M, Foppoli M, Martelli M, Pangalis G a, Frezzato M et al. High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial. Lancet 2009; 374: 1512–1520.

3. Ferreri AJM, Cwynarski K, Pulczynski E, Ponzoni M, Deckert M, Politi LS et al. Chemoimmunotherapy with methotrexate, cytarabine, thiotepa, and rituximab (MATRix regimen) in patients with primary CNS lymphoma: results of the first randomisation of the International Extranodal Lymphoma Study Group-32 (IELSG32) phase 2 trial. Lancet Haematol 2016; 3: e217–e227.

4. Abrey LE, Yahalom J, DeAngelis LM . Treatment for primary CNS lymphoma: the next step. J Cinical Oncol 2000; 18: 3144–3150.

5. Jahnke K, Korfel A, Martus P, Weller M, Herrlinger U, Schmittel A et al. High-dose methotrexate toxicity in elderly patients with primary central nervous system lymphoma. Ann Oncol 2005; 16: 445–449.

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Combination of rituximab and methotrexate followed by rituximab and cytarabine in elderly patients with primary central nervous system lymphoma;British Journal of Haematology;2024-08-05

2. Outcomes and relapse patterns in primary central nervous system lymphoma: Longitudinal analysis of 559 patients diagnosed from 1983 to 2020;Neuro-Oncology;2024-06-25

3. Diagnostics and treatment delay in primary central nervous system lymphoma: What the neurosurgeon should know;Acta Neurochirurgica;2024-06-11

4. Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up;Annals of Oncology;2024-06

5. Primary central nervous system lymphomas: EHA–ESMO Clinical Practice Guideline for diagnosis, treatment and follow‐up;HemaSphere;2024-06